- The stock price of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is trading at over 15% pre-market. This is why it happened.
The stock price of Titan Pharmaceuticals, Inc. common stock (NASDAQ: TTNP) is trading at over 15% pre-market as of 8:54 AM ET. Investors are responding to Titan Pharmaceuticals being upgraded to “Buy” from “Hold” at Maxim and an $11 price target.
The analysts pointed out Titan Pharmaceuticals underwent multiple changes around its management, strategy, capital structure, and financing last year and into this year. This is expected to position the stock and the ProNeura drug-delivery platform for the next chapter and it also presents attractive de-risked technology.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.